A Study of EDG-7500 in Healthy Adults

Clinical trial NCT06011317 · COMPLETED

Trial details

NCT number: NCT06011317
Sponsor: Edgewise Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2023-08-14
Primary completion: 2024-05-23
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.